Patent details
92426 Product Name: Canagliflozine
Basic Information
- Publication number:
- 92426
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP047713144
- Legal Status:
- Active
- Application number:
- 92426
- First applicant's nationality:
- Procedural language:
- French
Paediatric Extension
- SPC Extension Filing Date:
- 26/03/2026
- SPC Extension Agent Name:
- OFFICE FREYLINGER S.A.
- SPC Extension Status:
- Pending
- SPC Extension Grant Date:
- SPC Extension Rejection Date:
Marketing Authorization
- Marketing Authorization Number:
- EU/1/13/884 - Invokana - canagliflozin
- Marketing Authorization Type:
- Marketing Authorization Date:
- 19/11/2013
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 09/04/2014
- First Marketing Authorization date:
- 19/11/2013
- Grant date:
- 10/06/2014
- Activation date:
- 30/07/2024
- Publication date:
- 10/06/2014
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 19/11/2028
- SPC Extension Expiration:
- 19/05/2029
- Rejection date:
- Withdrawal date:
Owner
- From:
- 07/07/2016
- Name:
- MITSUBISHI TANABE PHARMA CORPORATION
- Address:
- 3-2-10, DOSHO-MACHI, CHUO-KU, OSAKA-SHI, OSAKA 541-8505, Japan (JP)
History of Owners
- From:
- 09/04/2014
- To:
- 06/07/2016
- Name:
- Mitsubishi Tanabe Pharma Corporation
- Address:
- 2-6-18, Kitahama Chuo-ku Osaka-shi, Osaka 541-8505, Japan (JP)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 09/04/2014
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- UETA Kiichiro c/o Mitsubishi Tanabe Pharma Corporation
- Address:
- Japan (JP)
2
- Name:
- KAWANISHI Eiji c/o Mitsubishi Tanabe Pharma Corporation
- Address:
- Japan (JP)
3
- Name:
- NOMURA Sumihiro c/o Mitsubishi Tanabe Pharma Corporation
- Address:
- Japan (JP)
Publication
Bulletin
1
- Bulletin Heading:
- SPC4
- Bulletin edition number:
- 2019/02
- Publication date:
- 22/02/2019
- Description:
- Section F : Correction of granted supplementary protection certificates – I9 publication
2
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2025/04
- Publication date:
- 04/03/2025
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
Annual Fees
- Annual Fee Due Date:
- 31/07/2026
- Annual Fee Number:
- 23
- Annual Fee Amount:
- 430 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 14/07/2025
- Last Annual Fee Paid Number:
- 22
- Last Annual Fee Paid Amount:
- 420 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 15/02/2016 | Incoming Correspondence (Post) | 3 |
| 16/01/2019 | Publication | 1 |
| 16/01/2019 | Outgoing Correspondence | 1 |
| 26/03/2026 | General Document | 3 |
| 26/03/2026 | Outgoing Correspondence | 2 |
| 26/03/2026 | General Document | 1 |
| 26/03/2026 | General Document | 1 |
| 26/03/2026 | General Document | 52 |
| 26/03/2026 | Application Form | 5 |
| 26/03/2026 | Marketing authorization | 3 |
| 26/03/2026 | Outgoing Correspondence | 1 |